IP Library Patent Application 12138924
Patent Application
App. No. 12/138,924

PROCESS FOR PREPARATION OF 5H DIBENZO[a,d] CYCLOHEPTENE DERIVATIVES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/138,924
Abstract

A process for preparation of protriptyline hydrochloride from 5-dihydrobenzocycloheptatriene of formula (1) by coupling with chloropropyl alcohol in the presence of excess n-butyl Lithium in tetrahydrofuran under inert atmosphere, followed by preparation of mesylate derivative of formula (3) and finally the nucleophilic displacement of the mesylate group by reacting methylamine solution in methanol to give protriptyline free base of the formula (4). Also the present process reveals the hydrochloride salt formation and purification of the same to give pure pharmaceutical grade protriptyline hydrochloride with impurities less than 0.1% w/w.

Claims (9)

1 . A process of preparing 3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-propan-1-ol comprising reacting 5-dihydro dibenzocycloheptatriene with chloro propyl alcohol in the presence of an excess of n-butyl lithium.

2 . The process of claim 1 wherein the step of preparing 3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-propan-1-ol comprises using 4 eq. of n-butyllithium and 1.05 eq. of 3-chloropropyl alcohol.

3 . A process of preparing a compound of formula (4)

comprising combining a compound of formula (3)

and methyl amine solution in a solvent selected from the group consisting of methanol, THF and water.

4 . The process in accordance with claim 3 wherein a 2.0M solution of Methyl amine in methanol is employed.

5 . The process in accordance with claim 3 wherein a 2.0M solution of Methyl amine in THF is employed.

6 . The process in accordance with claim 3 wherein methyl amine in water is employed in a concentration of 15% or greater.

7 . The process in accordance with claim 3 wherein a 15-30% solution of methyl amine solution in methanol is employed.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2021
From: MYLAN API US LLC
To: MYLAN LABORATORIES LIMITED
Reel/Frame 057685/0916 →
CHANGE OF NAME Recorded Oct 4, 2021
From: APICORE US LLC
To: MYLAN API US LLC
Reel/Frame 057697/0758 →
RELEASE OF SECURITY INTEREST Recorded Jan 9, 2017
From: KNIGHT THERAPEUTICS INC.
To: APICORE LLC
Reel/Frame 040904/0362 →
RELEASE OF SECURITY INTEREST Recorded Jan 9, 2017
From: KNIGHT THERAPEUTICS INC.
To: APICORE US LLC
Reel/Frame 040904/0390 →
SECURITY INTEREST Recorded Jul 8, 2014
From: APICORE US LLC
To: KNIGHT THERAPEUTICS INC., AS AGENT
Reel/Frame 033281/0920 →
SECURITY INTEREST Recorded Jul 3, 2014
From: APICORE LLC
To: KNIGHT THERAPEUTICS INC., AS AGENT
Reel/Frame 033277/0320 →